SUSCEPTIBILITIES OF BACTERIA ISOLATED FROM PATIENTS WITH LOWER RESPIRATORY INFECTIOUS DISEASES TO ANTIBIOTICS (1996)

• Published in: Japanese journal of antibiotics Vol. 51; no. 7; pp. 437 - 474
• Main Authors: IKEMOTO, HIDEO, WATANABE, KAZUYOSHI, MORI, TAKESHI, IGARI, JUN, OGURI, TOYOKO, SHIMIZU, YOSHINORI, TERAI, TSUGIO, INOUE, HIROSHI, NAKADATE, TOSHIHIDE, ITO, CHUICHI, YOSHIDA, TAKESHI, OHNO, ISAO, TANNO, YASUO, ARAKAWA, MASAAKI, IGARASHI, KENICHI, OKADA, MASAHIKO, OZAKI, KYOKO, AOKI, NOBUKI, KITAMURA, NOBUKO, SEKINE, OSAMU, SUZUKI, YASUTOSHI, NAKATA, KOUICHIRO, NAKATANI, TATSUO, INAGAWA, HIROKO, KUDO, KOUICHIRO, YAMAMOTO, YUMIKO, KOBAYASHI, HIROYUKI, KAWAI, SHIN, TAKAYASU, SATOSHI, SHIMADA, KAORU, NAKANO, KUNIO, TAKAMORI, MIKIO, YOKOUTI, HIROSI, ITO, AKIRA, SUMITOMO, MIDORI, KAKU, MITSUO, MATSUSHIMA, TOSHIHARU, NIKI, YOSHIHITO, ANDO, MASAYUKI, SUGA, MORITAKA, TOSAKA, MASAKAZU, KOHNO, SHIGERU, TOMONO, KAZUNORI, HIRAKATA, YOICHI, IZUMIKAWA, KOICHI, YAMAGUCHI, TOSHIYUKI, MATSUDA, JUNICHI, NASU, MASARU, ITO, MORIO, YAMASAKI, TOHRU, NAKANO, TADAO, SAITO, ATSUSHI, TOUYAMA, MASATO, YAMANE, NOBUHISA, KUSANO, NOBUTIKA
• Format: Journal Article
• Language: Japanese
• Published: Japan Japan Antibiotics Research Association 01.07.1998
• Subjects: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents - pharmacology; Drug Resistance, Microbial; Female; Haemophilus influenzae - drug effects; Haemophilus influenzae - isolation & purification; Humans; Klebsiella pneumoniae - drug effects; Klebsiella pneumoniae - isolation & purification; Male; Methicillin Resistance; Middle Aged; Moraxella (Branhamella) catarrhalis - drug effects; Moraxella (Branhamella) catarrhalis - isolation & purification; Pseudomonas aeruginosa - drug effects; Pseudomonas aeruginosa - isolation & purification; Respiratory Tract Infections - microbiology; Staphylococcus aureus - drug effects; Staphylococcus aureus - isolation & purification; Streptococcus pneumoniae - drug effects; Streptococcus pneumoniae - isolation & purification; Time Factors
• ISSN: 0368-2781; 2186-5477
• DOI: 10.11553/antibiotics1968b.51.437

The bacteria isolated from the patients with lower respiratory tract infections were collected by institutions located throughout Japan, since 1981. Ikemoto et al. have been investigating susceptibilities of these isolates to various antibacterial agents and antibiotics, and characteristics of the patients and isolates from them each year. Results obtained from these investigations are discussed. In 16 institutions around the entire Japan, 557 strains of presumably etiological bacteria were isolated mainly from the sputa of 449 patients with lower respiratory tract infections during the period from October 1996 to September 1997. MICs of various antibacterial agents and antibiotics were determined against 98 strains of Staphylococcus aureus, 93 strains of Streptococcus pneumoniae, 84 strains of Haemophilus influenzae, 84 strains of Pseudomonas aeruginosa (non-mucoid strains), 17 strains of Pseudomonas aeruginosa (mucoid strains), 31 strains of Moraxella subgenus Branhamella catarrhalis, 21 strains of Klebsiella pneumoniae etc., and the drug susceptibilities of these strains were assessed except for those strains that died during transportation. 1) S. aureus S. aureus strains for which MICs of oxacillin (MPIPC) were higher than 4 micrograms/ml (methicillin-resistant S. aureus) accounted for 67.3%. The frequency of the drug resistant bacteria increased comparing to the previous year's 52.7%. Arbekacin (ABK) and vancomycin (VCM) showed the highest activities against both S. aureus and MRSA with MIC80s of 1 microgram/ml. 2) S. pneumoniae Imipenem (IPM) and panipenem (PAPM) of carbapenems showed the most potent activities with MIC80s of 0.063 microgram/ml. Faropenem (FRPM) showed the next potent activity with MIC80 of 0.125 microgram/ml. The other drugs except erythromycin (EM), clindamycin (CLDM) and tetracycline (TC) were active against S. pneumoniae tested with MIC80s of 8 micrograms/ml or below. 3) H. influenzae The activities of all drugs were potent against H. influenzae tested with MIC80s of 4 micrograms/ml or below. Cefotiam (CTM), cefmenoxime (CMX), cefditoren (CDTR) and ofloxacin (OFLX) showed the most potent activities with MIC80s of 0.063 microgram/ml. 4) P. aeruginosa (mucoid strains) Tobramycin (TOB) showed the most potent activity against P. aeruginosa (mucoid strains) with MIC80 of 1 microgram/ml. Ceftazidime (CAZ), cefsulodin (CFS), IPM, gentamicin (GM), ABK and ciprofloxacin (CPFX) showed the next potent activities, with MIC80s of 2 micrograms/ml. The MIC80s of the other drugs ranged from 4 micrograms/ml to 16 micrograms/ml. 5) P. aeruginosa (non-mucoid strains) TOB and CPFX showed the most potent activities against P. aeruginosa (non-mucoid strains) with MIC80s of 1 microgram/ml. The MIC80s of piperacillin (PIPC) and cefoperazone (CPZ) were 16 micrograms/ml in 1995, and they were 64 micrograms/ml in 1996. 6) K. pneumoniae All drugs except ampicillin (ABPC) were active against K. pneumoniae. CMX, cefpirome (CPR), cefozopran (CZOP) and carumonam (CRMN) showed the most potent activities against K. pneumoniae with MIC80s of 0.125 microgram/ml. The MIC80s of the other drugs ranged from 0.25 microgram/ml to 2 micrograms/ml. 7) M.(B) catarrhalis Against M.(B.) catarrhalis, all drugs showed good activities with MICs of 4 micrograms/ml or below. IPM and minocycline (MINO) showed the most potent activities with MICs of 0.063 microgram/ml. Also, we investigated year to year changes in the characteristics of patients, their respiratory infectious diseases, and the etiology. Patients' backgrounds were examined for 557 isolates from 449 cases. The examination of age distribution indicated that the proportion of patients with ages over 60 years was 71.0% of all the patients showing a slight increase over that in 1994. Proportions of diagnosed diseases were as follows: Bacterial pneumonia and chronic bronchitis were the most frequent with 35.9% and 30.3% respectively. They were followed by bronchiectasis with a proportion of 10.